ESCO1 and CTCF enable formation of long chromatin loops by protecting cohesinSTAG1 from WAPL

  1. Gordana Wutz
  2. Rene Ladurner
  3. Brian Glenn St Hilaire
  4. Roman R Stocsits
  5. Kota Nagasaka
  6. Benoit Pignard
  7. Adrian Sanborn
  8. Wen Tang
  9. Csilla Várnai
  10. Miroslav P Ivanov
  11. Stefan Schoenfelder
  12. Petra van der Lelij
  13. Xingfan Huang
  14. Gerhard Dürnberger
  15. Elisabeth Roitinger
  16. Karl Mechtler
  17. Iain Finley Davidson
  18. Peter J Fraser
  19. Erez Lieberman-Aiden  Is a corresponding author
  20. Jan-Michael Peters  Is a corresponding author
  1. Research Institute of Molecular Pathology, Austria
  2. Baylor College of Medicine, United States
  3. Stanford University, United States
  4. University of Birmingham, United Kingdom
  5. The Francis Crick Institute, United Kingdom
  6. The Babraham Institute, United Kingdom
  7. University of Washington, United States
  8. Gregor Mendel Institute of Molecular Plant Biology, Austria
  9. Institute of Molecular Biotechnology, Austria

Abstract

Eukaryotic genomes are folded into loops. It is thought that these are formed by cohesin complexes via extrusion, either until loop expansion is arrested by CTCF or until cohesin is removed from DNA by WAPL. Although WAPL limits cohesin's chromatin residence time to minutes, it has been reported that some loops exist for hours. How these loops can persist is unknown. We show that during G1-phase, mammalian cells contain acetylated cohesinSTAG1 which binds chromatin for hours, whereas cohesinSTAG2 binds chromatin for minutes. Our results indicate that CTCF and the acetyltransferase ESCO1 protect a subset of cohesinSTAG1 complexes from WAPL, thereby enable formation of long and presumably long-lived loops, and that ESCO1, like CTCF, contributes to boundary formation in chromatin looping. Our data are consistent with a model of nested loop extrusion, in which acetylated cohesinSTAG1 forms stable loops between CTCF sites, demarcating the boundaries of more transient cohesinSTAG2 extrusion activity.

Data availability

Sequencing data have been deposited in GEO under accession code GSE138405. Please go to https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE138405

The following data sets were generated
The following previously published data sets were used

Article and author information

Author details

  1. Gordana Wutz

    Research Institute of Molecular Pathology, Vienna, Austria
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-6842-0795
  2. Rene Ladurner

    Research Institute of Molecular Pathology, Vienna, Austria
    Competing interests
    The authors declare that no competing interests exist.
  3. Brian Glenn St Hilaire

    Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, United States
    Competing interests
    The authors declare that no competing interests exist.
  4. Roman R Stocsits

    Research Institute of Molecular Pathology, Vienna, Austria
    Competing interests
    The authors declare that no competing interests exist.
  5. Kota Nagasaka

    Research Institute of Molecular Pathology, Vienna, Austria
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-0765-638X
  6. Benoit Pignard

    Research Institute of Molecular Pathology, Vienna, Austria
    Competing interests
    The authors declare that no competing interests exist.
  7. Adrian Sanborn

    Department of Computer Science, Stanford University, Stanford, United States
    Competing interests
    The authors declare that no competing interests exist.
  8. Wen Tang

    Research Institute of Molecular Pathology, Vienna, Austria
    Competing interests
    The authors declare that no competing interests exist.
  9. Csilla Várnai

    Centre for Computational Biology, University of Birmingham, Birmingham, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  10. Miroslav P Ivanov

    DSB Repair Metabolism, The Francis Crick Institute, London, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-9352-0969
  11. Stefan Schoenfelder

    Epigenetics Programme, The Babraham Institute, Cambridge, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-3200-8133
  12. Petra van der Lelij

    Research Institute of Molecular Pathology, Vienna, Austria
    Competing interests
    The authors declare that no competing interests exist.
  13. Xingfan Huang

    Departments of Computer Science and Genome Sciences, University of Washington, Washington, United States
    Competing interests
    The authors declare that no competing interests exist.
  14. Gerhard Dürnberger

    Gregor Mendel Institute of Molecular Plant Biology, Vienna, Austria
    Competing interests
    The authors declare that no competing interests exist.
  15. Elisabeth Roitinger

    Mechtler Laboratory, Institute of Molecular Biotechnology, Vienna, Austria
    Competing interests
    The authors declare that no competing interests exist.
  16. Karl Mechtler

    Research Institute of Molecular Pathology, Vienna, Austria
    Competing interests
    The authors declare that no competing interests exist.
  17. Iain Finley Davidson

    Research Institute of Molecular Pathology, Vienna, Austria
    Competing interests
    The authors declare that no competing interests exist.
  18. Peter J Fraser

    Nuclear Dynamics Programme, The Babraham Institute, Cambridge, United Kingdom
    Competing interests
    The authors declare that no competing interests exist.
  19. Erez Lieberman-Aiden

    Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, United States
    For correspondence
    erez@erez.com
    Competing interests
    The authors declare that no competing interests exist.
  20. Jan-Michael Peters

    Research Institute of Molecular Pathology, Vienna, Austria
    For correspondence
    Jan-Michael.Peters@imp.ac.at
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-2820-3195

Funding

NIH Clinical Center (5U01HL130010-05)

  • Erez Lieberman-Aiden

The Austrian Science Fund (Z196-B20 Wittgenstein award)

  • Jan-Michael Peters

The European community's Seventh Frame- work Programme (FP7/2007-2013 241548)

  • Jan-Michael Peters

Human Frontier Science Program (RGP0057/2018)

  • Jan-Michael Peters

NIH Clinical Center (5UM1HG009375-03)

  • Erez Lieberman-Aiden

National Science Foundation (PHY-1427654)

  • Erez Lieberman-Aiden

Horizon 2020 Framework Programme (EPIC-XS 823839)

  • Karl Mechtler

Austrian Science Fund by ERA-CAPS (3686 International Project)

  • Karl Mechtler

H2020 European Research Council (No 693949)

  • Jan-Michael Peters

Vienna Science and Technology Fund (WWTF LS09-13)

  • Jan-Michael Peters

The Austrian Science Fund (SFB F34)

  • Jan-Michael Peters

Austrian Research Promotion Agency (FFG-852936)

  • Jan-Michael Peters

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Copyright

© 2020, Wutz et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 6,165
    views
  • 1,003
    downloads
  • 140
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Gordana Wutz
  2. Rene Ladurner
  3. Brian Glenn St Hilaire
  4. Roman R Stocsits
  5. Kota Nagasaka
  6. Benoit Pignard
  7. Adrian Sanborn
  8. Wen Tang
  9. Csilla Várnai
  10. Miroslav P Ivanov
  11. Stefan Schoenfelder
  12. Petra van der Lelij
  13. Xingfan Huang
  14. Gerhard Dürnberger
  15. Elisabeth Roitinger
  16. Karl Mechtler
  17. Iain Finley Davidson
  18. Peter J Fraser
  19. Erez Lieberman-Aiden
  20. Jan-Michael Peters
(2020)
ESCO1 and CTCF enable formation of long chromatin loops by protecting cohesinSTAG1 from WAPL
eLife 9:e52091.
https://doi.org/10.7554/eLife.52091

Share this article

https://doi.org/10.7554/eLife.52091

Further reading

    1. Cell Biology
    Chengfang Pan, Ying Liu ... Changlong Hu
    Research Article

    Prostaglandin E2 (PGE2) is an endogenous inhibitor of glucose-stimulated insulin secretion (GSIS) and plays an important role in pancreatic β-cell dysfunction in type 2 diabetes mellitus (T2DM). This study aimed to explore the underlying mechanism by which PGE2 inhibits GSIS. Our results showed that PGE2 inhibited Kv2.2 channels via increasing PKA activity in HEK293T cells overexpressed with Kv2.2 channels. Point mutation analysis demonstrated that S448 residue was responsible for the PKA-dependent modulation of Kv2.2. Furthermore, the inhibitory effect of PGE2 on Kv2.2 was blocked by EP2/4 receptor antagonists, while mimicked by EP2/4 receptor agonists. The immune fluorescence results showed that EP1–4 receptors are expressed in both mouse and human β-cells. In INS-1(832/13) β-cells, PGE2 inhibited voltage-gated potassium currents and electrical activity through EP2/4 receptors and Kv2.2 channels. Knockdown of Kcnb2 reduced the action potential firing frequency and alleviated the inhibition of PGE2 on GSIS in INS-1(832/13) β-cells. PGE2 impaired glucose tolerance in wild-type mice but did not alter glucose tolerance in Kcnb2 knockout mice. Knockout of Kcnb2 reduced electrical activity, GSIS and abrogated the inhibition of PGE2 on GSIS in mouse islets. In conclusion, we have demonstrated that PGE2 inhibits GSIS in pancreatic β-cells through the EP2/4-Kv2.2 signaling pathway. The findings highlight the significant role of Kv2.2 channels in the regulation of β-cell repetitive firing and insulin secretion, and contribute to the understanding of the molecular basis of β-cell dysfunction in diabetes.

    1. Cell Biology
    Weihua Wang, Junqiao Xing ... Zhangfeng Hu
    Research Article

    Existence of cilia in the last eukaryotic common ancestor raises a fundamental question in biology: how the transcriptional regulation of ciliogenesis has evolved? One conceptual answer to this question is by an ancient transcription factor regulating ciliary gene expression in both uni- and multicellular organisms, but examples of such transcription factors in eukaryotes are lacking. Previously, we showed that an ancient transcription factor X chromosome-associated protein 5 (Xap5) is required for flagellar assembly in Chlamydomonas. Here, we show that Xap5 and Xap5-like (Xap5l) are two conserved pairs of antagonistic transcription regulators that control ciliary transcriptional programs during spermatogenesis. Male mice lacking either Xap5 or Xap5l display infertility, as a result of meiotic prophase arrest and sperm flagella malformation, respectively. Mechanistically, Xap5 positively regulates the ciliary gene expression by activating the key regulators including Foxj1 and Rfx families during the early stage of spermatogenesis. In contrast, Xap5l negatively regulates the expression of ciliary genes via repressing these ciliary transcription factors during the spermiogenesis stage. Our results provide new insights into the mechanisms by which temporal and spatial transcription regulators are coordinated to control ciliary transcriptional programs during spermatogenesis.